Form 4 for PGEN PRECIGEN, INC.
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-04 · accession 0000950103-23-000200 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-06 | 2023-01-04 | PGEN | Sabzevari Helen | Pres, CEO, Dir | M - OptEx | — | +17.7K | 914.8K | +2% | — |
| D | 2023-01-06 | 2023-01-04 | PGEN | Sabzevari Helen | Pres, CEO, Dir | M - OptEx | $0.00 | -17.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-04 | M | A | 17,665 | — | 914,756 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| 2 | Derivative | Restricted Stock Units | 2023-01-04 | M | D | 17,665 | $0.00 | 0 | D | — · — to — | 17,665 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. (F2) The RSUs were granted on January 4, 2019 and January 25, 2019 and have vested in full. |